Show simple item record

dc.contributor.authorRibeiro, G
dc.date.accessioned2011-06-23T16:49:18Z
dc.date.available2011-06-23T16:49:18Z
dc.date.issued1976-04
dc.identifier.citationThe results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast. 1976, 33 (4):465-7 Br J Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid1268034
dc.identifier.urihttp://hdl.handle.net/10541/134331
dc.description.abstractA retrospective survey has been made of 58 patients with recurrent and advanced male breast cancer treated with oral diethylstilboestrol. Fifty-five patients were suitable for assessment. Fourteen patients had an objective response and 7 had a partial response giving a total response of 21/55 patients (38%). The median remission for the objective responders was 7 years. Three patients are alive and free of disease; one has now been in remission for 13 years. It is suggested that diethylstilboestrol is a useful treatment in patients with soft tissue disease (breast, chest wall and/or lymph nodes).
dc.language.isoenen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBone Neoplasms
dc.subject.meshBreast Neoplasms
dc.subject.meshDiethylstilbestrol
dc.subject.meshHumans
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Metastasis
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshRetrospective Studies
dc.titleThe results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiotherapy, The Christie Hospital & Holt Radium Institute, Manchesteren
dc.identifier.journalBritish Journal of Canceren
dc.identifier.pmcidPMC2025078
html.description.abstractA retrospective survey has been made of 58 patients with recurrent and advanced male breast cancer treated with oral diethylstilboestrol. Fifty-five patients were suitable for assessment. Fourteen patients had an objective response and 7 had a partial response giving a total response of 21/55 patients (38%). The median remission for the objective responders was 7 years. Three patients are alive and free of disease; one has now been in remission for 13 years. It is suggested that diethylstilboestrol is a useful treatment in patients with soft tissue disease (breast, chest wall and/or lymph nodes).


This item appears in the following Collection(s)

Show simple item record